Searched for
SYNTHETIC DATA IN DRUG DEVELOPMENT
Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...- US drug regulator issues import alert for drugs made at a Dabur India plantThe US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed si...
- Deezer launches free AI music detector for users of major streaming platformsDeezer has introduced a free online tool to identify AI-generated songs on streaming platforms. The music company is also sharing its AI de...
- Weight-loss drugs trim UK food bills by $1 billionHouseholds with at least one user of GLP-1 weight-loss drugs bought 299 million fewer food items in the year after adoption of the medicati...
- Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
- India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...
- Global watchdog calls for tighter controls on agentic AI in financeThe Financial Stability Board (FSB) in a report on Wednesday "strongly" encouraged boards to consider implementing safeguards to mitigate r...
- Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
- AI world vastly different from IT Act era, believe new law is needed: Union minister VaishnawIndia's IT Minister Ashwini Vaishnaw believes a new law is needed for Artificial Intelligence. The current IT Act, enacted in 2000, predate...
- From chatbots to behavioural AI: Stanford study reveals emerging AI personality systemsAI is increasingly simulating stable human-like behaviour, often perceived as personality. Stanford HAI research shows these patterns arise...
- In 1916, chemists hunting a soap substitute made a cleaner that worked in hard water, and laundry detergent changed washing foreverThe demand for cleaner solutions during World War I led to the invention of synthetic detergents. These groundbreaking products outperforme...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
- In 1934, a chemist pulled a sticky polymer into a thread, and nylon moved toward everyday lifeIn a twist of fate, a humble lab experiment by chemist Julian Hill in the 1930s turned a sticky substance into a global phenomenon. What st...
- In 1907, a chemist was chasing a shellac substitute when a hard resin changed the age of plasticIn an unassuming quest for new industrial materials, Leo Baekeland ignited a transformative shift. His pursuit of a shellac alternative led...
- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- ED raids in Maharashtra, Gujarat in Salim Dola drugs caseThe Enforcement Directorate conducted raids across Maharashtra and Gujarat. The probe targets Mohammad Salim Dola, an alleged drug traffick...
- AI-Powered drug discovery could transform treatment development for Alzheimer’s, Parkinson’s and other brain disorders.Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s, Parkinson’s,...
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
Load More
